| Application no. and date | 08742674.8 (espacenet) (Federated) (European Patent Register), 20080408 | | Patent/reg. no. and date | DK/EP 2139483, 20130918 | | Publication date | 20100106 | | Priority no. and date | US 923164 P, 20070411 | | EP pub. no. and date |
EP 2139483 20100106 | | Effective date | | | Applicant/owner | Exelixis, Inc., 210 East Grand Avenue
South San Francisco, CA 94080, US | | Applicant ref. no. | P114015.DK.01/NWH | | Inventor | LAMB, Peter, 814 Mandana Blvd
Oakland, California 94610, US,
MATTHEWS, David, 2 Balceta Avenue
San Francisco, California 94127, US | | Representative | MURGITROYD & COMPANY, Mannerheimvägen 12B, 5tr
FI-00100 Helsingfors, FI | | Opponent | | | IPC Class | A61K 31/337 (2006.01) , A61K 31/436 (2006.01) , A61K 31/497 (2006.01) , A61K 31/498 (2006.01) , A61K 31/4985 (2006.01) , A61K 31/517 (2006.01) , A61K 31/555 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) | | Title | Kombinationsterapier, der omfatter en quinoxalin-inhibitor af PI3K-alfa, til anvendelse til behandling af cancer | | Int. application no. | US2008004570 | | Int. publication no. | WO2008127594 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
